There are a lot of health reform ideas being floated lately – Medicare-for-all and variations on the theme – that sound similar but are really quite different. Here’s an over-simplified cheat tweet.
Medicare-for-all: Everyone is in a public plan.
Optional Medicare-for-all: People can join a public plan or stay in employer coverage.
Public option: People with individual insurance can join a public plan.
Buy-in: Certain groups (e.g., age 50+) can join a public plan.
When looking at public plan or buy-in options that are not Medicare-for-all, I think the key questions are:
Who can join the public plan?
What do people have to pay?
What is covered?
How much do providers get paid?
How is it financed?
We have an interactive summary of Congressional Medicare-for-all and public plan proposals, which we will continually update as new bills are introduced. kff.org/interactive/co…
I'd welcome friendly amendments for what we should be calling these proposals that expand public coverage options but are not Medicare-for-all, and what key factors differentiate the proposals.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A record 13.6 million people have signed up for ACA coverage.
This enrollment growth is being driven by increased premium assistance in the American Rescue Plan, a reversal of cuts in outreach, and an administration touting rather than trashing the ACA.
These ACA enrollment gains are at risk if Build Back Better does not pass and extend the American Rescue Plan's enhanced premium assistance beyond next year.
Enrollees would get notice of big premium increases right before the midterm election if premium help isn't extended.
President Biden has not accomplished everything he set out to do in health care, but you have to credit him with fulfilling his promise to reinvigorate the Affordable Care Act.
The Biden Administration will be distributing 500 million rapid at-home COVID tests for free.
We don't want to be hermits, so we'll want to be using more tests than that to continue gathering safely during the winter wave. This sends an important signal about how to do so.
The Biden Administration previously announced that insurers will be required to reimburse for rapid at-home tests people buy. While cumbersome, that will help make tests more affordable for people, supplementing the distribution of 500 million free tests.
Unfortunately, right now, in the lead-up to the holidays, rapid tests are sold out in many stores and the cost is out of reach for many.
CBO estimates that capping cost-sharing for insulin at $35 per month in the Build Back Better Act would decrease federal revenue by $4.6 billion over a decade, which is an indication of how much people who use insulin would save.
Filling the Medicaid coverage gap has become a contentious political issue. How many people know what it is and how it originated?
The ACA originally envisioned a seamless system of health coverage eligibility.
States were required to expand Medicaid to everyone with incomes up to 138% of the poverty level.
People with incomes 138-400% of the poverty level were eligible for premium subsidies.
In 2012 the Supreme Court threw a massive curveball at the ACA's seamless coverage system.
Even though the federal government was initially covering 100% of the cost of the Medicaid expansion, phasing down to 90%, the court ruled that it had to be voluntary.
A big reason why the public overwhelmingly supports government negotiation of drug prices is that they don't buy the drug industry's arguments against it.
93% of people believe drug companies would still make enough to invest in research, even if prices in the U.S. were lower.
So much of the debate over the Build Back Better package has been on new spending and the overall price tag.
The provision that could prove to be among the most popular -- negotiation of drug prices -- saves money for both the government and patients.